African-American Women More Likely to Be Diagnosed with Higher Risk Breast Cancer
A research study led by cancer specialists at MedStar Washington Hospital Center found that African-American women frequently present with biologically less favorable subtypes of breast cancer.
June 9, 2014
Explore By Category :
- Ambulatory
- Cancer
- Cardiology
- Emergency medicine/trauma
- Geriatrics
- Healthcare industry
- Innovation
- Medical Education
- MedStar in the community
- Neurosciences
- Nursing
- Oncology
- Orthopaedics and sports medicine
- Pediatrics
- Quality and Patient Safety
- Rehabilitation
- Research
- Technology/IT
- Transplantation
- Urology
- Vascular
- Women’s services
- Video Gallery
- MedStar Harbor Hospital News
- MedStar Georgetown University Hospital News
- MedStar Good Samaritan Hospital News
- MedStar Franklin Square Medical Center News
- MedStar Union Memorial Hospital News
- MedStar Montgomery Medical Center News
- MedStar St. Mary's Hospital News
- MedStar Health System News
- MedStar Southern Maryland Hospital Center News
MedStar Washington Hospital Center Analyzes Data on Molecular Subtypes of Breast Cancer
Washington, D.C., June 9, 2014 – A research study led by cancer specialists at MedStar Washington Hospital Center found that African-American women frequently present with biologically less favorable subtypes of breast cancer.
Researchers at the Hospital Center’s Washington Cancer Institute analyzed the biology of breast cancer in 100 African-American women, using a method of genomic profiling. These genomic tests look at the expression of genes associated with the risk of recurrence in the population and further characterizes the biology of the tumor. The 70-gene MammaPrint test was used to determine the likelihood of a cancer recurrence. Out of the 100 patients, 66 women in the study were found to be high risk, meaning that their tumors had a higher risk of recurrence.
A companion BluePrint test was used to define the specific molecular subtype of each cancer. When classified by both genomic tests, African- American women with stage I to III breast cancer often presented with gene expression subtypes that were less favorable. The co-author of the research, Raquel Nunes, MD, a medical oncologist at the Washington Cancer Institute, presented the data as a scientific poster at the recent American Society of Clinical Oncology annual meeting.
“It’s important that research continues to address these issues comprehensively, from the biology of the disease to the development of optimal treatment and access to healthcare.” said Dr. Nunes. “This work is particularly meaningful for us because it complements our interest in health disparities and highlights the enthusiastic participation of African-Americans in breast cancer research.”
Unlike genetic tests such as those for BRCA genes (which are inherited and look at overall susceptibility for developing breast cancer), genomic tests look at the genes inside a breast cancer cell and how strongly they are expressed. The findings support prior research that has looked at the biologic characteristics of breast cancer in African-American women, but this specific methodology reported here was used for the first time in this population.
Cancer specialists will continue to follow the patients in the research study over the next five years to evaluate their survival with treatment, according to their gene profile.
Media Contacts
Sylvia Ballinger
202-877-7072
[email protected]
So Young Pak
202-877-2748
[email protected]
Category : Cancer , Women’s services ,
Back to Top
Related News

National Cancer Institute Renews Prestigious Designation of Georgetown Lombardi Comprehensive Cancer Center
Category : Cancer , Oncology , Research ,

High Rate of Advanced Colon Cancer Found Among African Americans in Ward 5
Category : Cancer , Tags : Advanced colon cancer , African-Americans , Cancer Moonshot , colon cancer , Colon cancer in the Neighborhood , colon cancer prevention , colon cancer screening , colonoscopy , Elmer Huerta , fecal immunochemical tests , FIT , health insurance , MedStar Washington Hospital Center , Ward 5 ,

Innovative Technology Improves Detection of Bladder Cancer
Category : Cancer , Innovation , Urology ,

The Leukemia & Lymphoma Society Recognizes Nurse Joy Moore as 2015 Hematology/Oncology Nurse of the Year
Category : Cancer , Oncology ,

MedStar Washington Hospital Center Receives Additional $100K Grant from Avon Foundation for Women to Continue Breast Cancer Outreach in Ward 5
Category : Healthcare industry , MedStar in the community , Women’s services ,

What Every Woman Needs to Know About Breast Cancer
Category : Cancer , Women’s services ,

Drug/Chemotherapy Combination Lengthens Survival for Patients with Aggressive Form of Breast Cancer
Category : Cancer , Healthcare industry , Innovation ,

Two Women's Health Practices Receive Distinct Certification for Excellence in Patient Safety
Category : Healthcare industry , Quality and Patient Safety , Women’s services ,